NVE (NVEC) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Annual Meeting scheduled for August 1, 2024, at company headquarters in Eden Prairie, MN.
Shareholders will vote on director elections, executive compensation, and auditor ratification.
Proxy materials include the 2024 Proxy Statement, Letter to Shareholders, and Annual Report on Form 10-K.
Voting matters and shareholder proposals
Election of five directors is on the agenda.
Advisory vote on named executive officer compensation will be held.
Ratification of Boulay PLLP as independent registered public accounting firm for fiscal year ending March 31, 2025.
Board recommends voting FOR all director nominees and FOR Proposals 2 and 3.
Board of directors and corporate governance
Only shareholders of record as of June 7, 2024, are entitled to vote at the meeting.
Partial view of Summaries dataset, powered by Quartr API
Latest events from NVE
- Quarterly revenue rose 23% and net income 11% year-over-year, with a $1.00 dividend declared.NVEC
Q3 20263 Feb 2026 - Revenue and net income declined, but gross margin and cash returns to shareholders remained strong.NVEC
Q1 20253 Feb 2026 - Gross margin rose to 86% as R&D revenue surged and a $1.00 dividend was declared.NVEC
Q2 202519 Jan 2026 - Revenue and net income fell, but gross margin improved to 84% and a dividend was declared.NVEC
Q3 20259 Jan 2026 - Maintained strong earnings, expanded R&D, and appointed a new director with medical expertise.NVEC
Proxy Filing1 Dec 2025 - Annual meeting to elect directors, approve pay, and ratify auditor, with focus on ESG and governance.NVEC
Proxy Filing1 Dec 2025 - Key votes on directors, executive pay, and auditor ratification, with strong governance and ESG focus.NVEC
Proxy Filing1 Dec 2025 - Shareholders receive updated proxy materials and online access for upcoming governance votes.NVEC
Proxy Filing1 Dec 2025 - Strong earnings, R&D investment, and 39% shareholder return highlight a year of innovation and growth.NVEC
Proxy Filing1 Dec 2025